BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17313470)

  • 1. Cytomegalovirus infection with perineal pain after living donor liver transplantation: report of four cases.
    Sakamoto S; Taira K; Egawa H; Takada Y
    Transpl Infect Dis; 2007 Mar; 9(1):37-41. PubMed ID: 17313470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of cytomegalovirus infection after living donor liver transplantation.
    Akamatsu N; Sugawara Y; Kaneko J; Kishi Y; Makuuchi M
    Hepatogastroenterology; 2005; 52(61):197-9. PubMed ID: 15783029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prevention and treatment of cytomegalovirus infection after liver transplantation].
    Zheng SS; Jiang ZJ; Xu X; Liang TB; Wang WL; Shen Y; Zhang M; Lu AW
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):584-6. PubMed ID: 15938930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors for cytomegalovirus infection after orthotopic liver transplantation using an ultrasensitive polymerase chain reaction assay.
    Basse G; Esposito L; Mengelle C; Kamar N; Ribes D; Lavayssière L; Pillet A; Suc B; Barange K; Rostaing L
    Transplant Proc; 2006 Sep; 38(7):2339-41. PubMed ID: 16980084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis.
    Rayes N; Seehofer D; Kahl A; Kokott S; Pratschke J; Frei U; Neuhaus P
    Transpl Int; 2007 Nov; 20(11):974-81. PubMed ID: 17680782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests.
    Fica A; Cervera C; Pérez N; Marcos MA; Ramírez J; Linares L; Soto G; Navasa M; Cofan F; Ricart MJ; Pérez-Villa F; Pumarola T; Moreno A
    Transpl Infect Dis; 2007 Sep; 9(3):203-10. PubMed ID: 17511827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral valganciclovir versus intravenous ganciclovir as preemptive treatment for cytomegalovirus infection after living donor liver transplantation: a randomized trial.
    Togashi J; Sugawara Y; Hashimoto M; Tamura S; Kaneko J; Aoki T; Hasegawa K; Kokudo N
    Biosci Trends; 2011; 5(5):217-22. PubMed ID: 22101378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute esophageal necrosis (black esophagus) in the renal transplant recipient: manifestation of primary cytomegalovirus infection.
    Trappe R; Pohl H; Forberger A; Schindler R; Reinke P
    Transpl Infect Dis; 2007 Mar; 9(1):42-5. PubMed ID: 17313471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HHV-6 and HHV-7 antigenemia related to CMV infection after liver transplantation.
    Härmä M; Höckerstedt K; Lyytikäinen O; Lautenschlager I
    J Med Virol; 2006 Jun; 78(6):800-5. PubMed ID: 16628583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus-associated chorioretinitis after liver transplantation: case report and review of the literature.
    Egli A; Bergamin O; Müllhaupt B; Seebach JD; Mueller NJ; Hirsch HH
    Transpl Infect Dis; 2008 Feb; 10(1):27-43. PubMed ID: 18086275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preemptive therapy with ganciclovir 5 mg/kg once daily for cytomegalovirus infection after unrelated cord blood transplantation.
    Tomonari A; Takahashi S; Ooi J; Tsukada N; Konuma T; Kobayashi T; Takasugi K; Iseki T; Tojo A; Asano S
    Bone Marrow Transplant; 2008 Feb; 41(4):371-6. PubMed ID: 17982495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute infection of Toxoplasma gondii and cytomegalovirus reactivation in a pediatric patient receiving liver transplant.
    Galván Ramírez ML; Castillo-de-León Y; Espinoza-Oliva M; Bojorques-Ramos MC; Rodríguez-Pérez LR; Bernal Redondo R; Cañedo-Solares I; Espinoza López L; Correa D
    Transpl Infect Dis; 2006 Dec; 8(4):233-6. PubMed ID: 17116139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo ulcerative colitis and autoimmune hepatitis after living related liver transplantation from cytomegalovirus-positive donor to cytomegalovirus-negative recipient: a case report.
    Sakamoto T; Sato Y; Yamamoto S; Oya H; Hatakeyama K
    Transplant Proc; 2012 Mar; 44(2):570-3. PubMed ID: 22410071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with cytomegalovirus infection in orthotopic liver transplant patients.
    Hoppe L; Marroni CA; Bressane R; Lago L; Schiavo FL; Cigerza GC; Brandão AB; Zanotelli ML; Cantisani GP
    Transplant Proc; 2006; 38(6):1922-3. PubMed ID: 16908324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of cytomegalovirus infection and disease after lung or heart-lung transplantation with a delayed ganciclovir regimen.
    Thomas LD; Milstone AP; Miller GG; Loyd JE; Stephen Dummer J
    Clin Transplant; 2009; 23(4):476-83. PubMed ID: 19453645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus disease with atypical presentation in a renal transplant patient: case report.
    Khosravi M; Nobakht A; Nikokar AR
    Exp Clin Transplant; 2006 Jun; 4(1):458-61. PubMed ID: 16827643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual endoscopic findings of CMV esophagitis after liver transplantation.
    Harada N; Shimada M; Suehiro T; Soejima Y; Ninomiya M; Shiotani S; Sugimachi K
    Hepatogastroenterology; 2005; 52(64):1236-9. PubMed ID: 16001670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
    Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients.
    Matsumura T; Narimatsu H; Kami M; Yuji K; Kusumi E; Hori A; Murashige N; Tanaka Y; Masuoka K; Wake A; Miyakoshi S; Kanda Y; Taniguchi S
    Biol Blood Marrow Transplant; 2007 May; 13(5):577-83. PubMed ID: 17448917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
    Rodriguez J; Casper K; Smallwood G; Stieber A; Fasola C; Lehneman J; Heffron T
    Liver Transpl; 2007 Oct; 13(10):1396-400. PubMed ID: 17902124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.